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Multi-Centre Analysis of Incidental Findings on Low-Resolution CT Attenuation 
Correction Images 
 
Abstract 
 
Objectives: To review new incidental findings detected on low-resolution CT 
attenuation correction (CTAC) images acquired during SPECT-CT myocardial 
perfusion imaging (MPI). To determine whether the CTAC images had diagnostic 
value and warrant reporting.  
 
Methods: A multi-centre study was performed in four UK Nuclear Medicine 
departments.  CTAC images acquired as part of MPI performed using SPECT were 
evaluated to identify incidental findings.  New findings considered to be clinically 
significant were evaluated further.  Positive predictive value (PPV) was determined 
at the time of definitive diagnosis. 
 
Results: Of 1819 patients studied, 497 (27%) had a positive CTAC finding. Fifty-one 
(2.8%) patients had findings that were clinically significant at the time of CTAC report 
and had not been previously diagnosed.  Only 4 (0.2%) of these were potentially 
detrimental to patient outcome.  
 
Conclusion: One centre had a PPV of 0% and the study suggests that these CTAC 
images should not be reported.  Two centres with more modern equipment had low 
PPVs of 0% and 6%, respectively, and further research is suggested prior to drawing 
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a conclusion.  The centre with best quality CT had a PPV of 67% and the study 
suggests that CTAC images from this equipment should be reported. 
 
Advances in knowledge: This study is unique compared with previous studies which 
have reported only the potential to identify incidental findings on low-resolution CT 
images.  This study both identifies and evaluates new clinically significant incidental 
findings and it demonstrates that the benefit of reporting the CTAC images depends 
on the type of equipment used. 
 
Introduction 
 
Myocardial perfusion imaging (MPI) performed using single-photon emission 
computed tomography (SPECT) is  often subject to artifact due to the scatter and 
absorption of photons prior to detection.  These artifacts can mimic myocardial 
perfusion defects leading to false-positive findings.  It has been demonstrated that 
CT attenuation correction (CTAC) can compensate for these errors in SPECT MPI, 
resulting in image quality improvement and more accurate diagnosis. 1,2 The low-
resolution/low-dose CT scan is performed through the area of the chest which is 
aligned with the SPECT scan of the heart, so only a limited CT scan of the thorax is 
acquired.   CT images are essentially a by-product of the attenuation correction (AC) 
process, the CT acquisition being primarily for AC purposes. 
 
Acquisition using a low tube current (mA) and large slice thickness results in images 
that have low signal-to-noise ratio, poor spatial resolution and an increased potential 
for partial volume artifacts compared to those of diagnostic CT studies.  Motion 
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artifacts may also be evident, as patients are not required to hold their breath during 
the CT acquisition.  The resulting images are adequate for the purpose for which 
they have been acquired, but are often not considered to be of diagnostic quality. 
The latest guidelines from the British Nuclear Cardiology Society suggest that if the 
CTAC images are of diagnostic quality then it is good practice to review them 
according to a local policy 3, but the guidelines do not specify what constitutes 
‘diagnostic quality’.  However, the CTAC images often reveal incidental findings. 4,5  
This would suggest that whilst the images are of lower quality than a diagnostic CT 
scan they could potentially have some diagnostic value.   
 
In the UK, the Ionising Radiation (Medical Exposure) Regulations 2000 (IR(ME)R 
2000) 6 stipulate that each medical radiation exposure should be evaluated and a 
record kept of any findings.  Although this implies that CTAC images should be 
reported this is ambiguous because of the non-diagnostic nature of the images and 
lack of professional body guidance. 3,7 
 
The objectives of this study were: 
  
1. To review the new incidental findings that were detected on low-resolution 
CTAC images acquired during SPECT-CT MPI that were thought to be 
clinically significant at the time of reporting.   
2. To determine whether the CTAC images had diagnostic value and warranted 
reporting.   
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In this study we considered ‘clinically significant’ to mean that there was a high 
suspicion that the pathology, if any, underlying the incidental radiologic finding could 
impact negatively on patient well-being and that further investigation was required. 
 
Method 
A multi-centre study of four UK nuclear medicine departments was carried out. Low-
resolution CTAC images from all SPECT MPI studies acquired between 1 July 2010 
and 30 June 2011 were included in the study and evaluated in order to determine the 
number of incidental findings.  All patients referred for MPI with CTAC whose 
examination resulted in a written report by a consultant radiologist were included. . 
Their demographics are indicated in Table 1.  The mean ages of patients were 
similar and typical of patients undergoing CTAC for MPI. 
 
To reduce inter-interpreter reporting bias, studies were reported by a consultant 
radiologist.  A proforma informed by the Royal College of Radiologists guidance [8] 
was used to determine the content and structure of the written consultant report.  
Each report stated that the images formed part of a low-resolution/low quality CT that 
was produced as part of a nuclear medicine myocardial perfusion study.  This 
ensured that it was clear to any clinician reading the report that the CT scan had not 
been performed for diagnostic purposes.  Both non-significant and potentially 
significant abnormalities were noted in the report and if there was no abnormality 
detected, this was also noted.   Identification of previously unknown significant 
findings was communicated 9 and managed in accordance with the policy of each 
individual hospital.  
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The four consultant radiologists held regular case discussion meetings where they 
were able to share interesting cases and discuss discrepancies.  This, in addition to 
the use of the standard proforma, helped to ensure reporting concurrence and so 
provide a method of quality assurance. 8  
 
As incidental findings were possible in any of the tissues within the thorax, the 
images were reviewed on a variety of CT window settings in order to adequately 
visualise lung, bone and soft tissue. 
 
After taking advice from the Health Research Authority (HRE), approval for this study 
was sought locally from each participating hospital and was granted as medical audit 
from one centre and as service evaluation from the other three centres.  Ethical 
approval was obtained from the University of Salford. 
 
Technical Scanning Parameters 
 
The SPECT-CT equipment installed in the four centres utilised CT scanners with 
varying capabilities. Scan parameters for each CT system are shown in Table 2.  
Centre 1 used a GE Infinia Hawkeye 1-slice incremental CT scanner.  The 
parameters available with this scanner were the most limited. The CT images from 
centres 2 and 3 were acquired using a GE Infinia Hawkeye 4 system which had a  4-
slice multi-detector CT (MDCT) scanner.  The scan parameters available were still 
limited and the available tube currents were 1, 1.5, 2.0 and 2.5 mA.  Centre 4 utilised 
a Philips Precedence 16-slice MDCT with the availability for diagnostic parameters to 
be selected. 
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The GE Infinia Hawkeye 1 used a low tube current of 2.5 mA in axial mode (effective 
pitch of 1), with a tube rotation time of 30 seconds.  Half-scan mode was utilized, 
meaning that the x-ray tube was only “on” for 18 seconds per slice, corresponding to 
an effective 45 mAs. The GE Infinia Hawkeye 4 scanner used 1.5 mA in helical 
mode with a pitch of 1.9, which equates to an effective 24 mAs. The Philips 
Precedence 16-slice scanner used approximately 33 mA with a rotation time of 1.5 
seconds and a pitch of 0.98 to produce 50 mAs.  The acquired slice thickness and 
pitch used with the Philips Precedence was similar to diagnostic MDCT although the 
reconstructed slice thickness was close to the reconstructed slice thickness of the 
Infinia Hawkeye 4.  The Infinia Hawkeye 4 used a larger acquired slice thickness and 
pitch and the Infinia Hawkeye 1 had the largest acquired slice thickness of 10mm. 
 
Acquisition using a large slice thickness and the use of a large pitch both contribute 
to reduced spatial resolution and the potential for increased partial volume 
averaging.  Also, the Hawkeye acquisitions were performed with the patient free-
breathing whereas the Philips Precedence images were acquired with a breath-hold. 
It was therefore expected that the CTAC images produced by the Infinia Hawkeye 
systems would have reduced quality relative to the CTAC images produced by the 
Philips Precedence CT.  This would be consistent with findings from a lesion 
detection study performed by Thompson et al, 2014 using an anthropomorphic 
phantom to acquire images on different SPECT-CT systems. 10 The SPECT-CT 
systems were operated with site-specific acquisition parameters and observer 
performance of lesion detection was found to correlate with variation in CTAC 
protocols. 
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Image Evaluation 
 
From the four centres a total of 1819 patients were reported and included in this 
study.  If patients had both stress and rest studies performed these were considered 
as one examination for the purpose of this study.  The radiologists’ written reports 
were reviewed retrospectively.  Reports which identified only previously known 
pathology were not included in the final evaluation because, if necessary, this 
pathology would be followed up with diagnostic CT as part of the patient’s routine 
management.  Review of the CTAC images would not influence management for 
these patients.  In addition, CTAC images are not suited to longitudinal assessment 
of pathology and so could not substitute for diagnostic CT as a follow-up tool.  
Therefore, only findings of previously unknown conditions were considered; we have 
called these new positive findings.  
 
Patients who had positive findings were noted and their case history records were 
then reviewed.  New positive findings were classified according to the clinical 
significance at the time of report.  The classification system was adapted from the 
one used by Goetze et al (2006) 11 and is shown in table 3.  
 
Only findings that were classified as major were considered to be clinically significant 
and warranted follow-up. Potentially, these findings could affect the clinical 
management of the patient. For the purposes of this analysis only major findings of 
pathology that were not previously known have been considered as significant new 
incidental findings.  All other findings were considered to be insignificant. 
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The primary outcome was to determine the positive predictive value (PPV) of the 
CTAC images for patients who had clinically significant new positive findings.  These 
patients all received follow-up procedures (e.g. diagnostic CT, plain radiographs or 
interventional procedures) over a period of up to two years.  This enabled 
assessment of the final diagnostic outcome in these patients, which in turn informed 
the value of interpreting the CTAC images.  It was not possible, either practically or 
ethically, to follow-up patients who had no positive findings on the CTAC images and 
so this study could not determine the number of true- and false-negative results.  
 
In order to indicate the performance of detecting pathology on the CTAC images that 
would be detrimental to the patient if undetected, the PPV has been calculated at the 
time the definitive diagnosis was made, rather than at the time of the CTAC report.  
Therefore, PPV was calculated as the percentage of new significant findings which 
ultimately affected patient outcome.                                             
 
Results 
 
Table 4 summarises the results. Out of 1819 patients studied 497 (27%) had a 
positive finding of any type, of which 423 (23%) were new findings.  Fifty-one (2.8%) 
patients had findings that were considered clinically significant at the time of CTAC 
report and which had not been previously diagnosed.  However, only 4 (0.2%) of 
these findings had the potential to be detrimental to patient outcome.  
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Although there was a much higher number of findings that were considered to be 
significant new incidental findings at the time of the CTAC scan, many of these 
pathologies resolved, remained stable (no change in size or appearance which might 
otherwise suggest malignancy) or proved to be insignificant when the patient was 
followed-up. 
 
Location and Characterisation of New Significant Incidental Findings  
Only 51 out of 497 (10%) of positive findings were both new and clinically significant. 
The location of these findings fell into three categories; pulmonary (8%), 
cardiovascular (1.8%) and para-spinal (0.4%) (see table 5).  The most common 
lesions detected on CTAC were pulmonary in nature and included pulmonary 
nodules (2.2%), effusion (2.0%), consolidation (1.6%), pulmonary mass (0.6%), lung 
metastases (0.4%), ground glass opacities (GGO) (0.2%), atelectasis (0.2%), 
pneumonia (0.2%) and lobar collapse (0.2%).  Findings within the cardiovascular 
system were predominantly coronary artery calcifications (1.6%) but there was also 
one aortic aneurysm detected (0.2%).  The two para-spinal lesions were masses 
located adjacent to thoracic vertebrae (0.4%). 
 
Discussion 
Out of 1819 patients undergoing SPECT-CT MPI studies, 423 patients (23%) had 
some abnormality found on the CT image that was not previously known. Of these, 
51 (2.8%) were serious enough to require further investigation.  However, after 
follow-up the significance of the diagnosis for 47 of these patients was downgraded, 
leaving only 4 (0.2%) with confirmed clinically significant pathology. Three patients 
(0.16%) had life-threatening pathologies that were treated as a result of their 
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detection on CTAC images.  One patient (0.05%) was diagnosed with a condition 
that had advanced beyond curative treatment. 
 
Centre 1 used an Infinia Hawkeye 1-slice CT system. Out of 322 patients they found 
12 who were considered to have new significant incidental findings at the time of the 
report.  However, on follow-up none of these findings were considered to be 
significant.  Six patients had consolidation that resolved over time and one had a 
pleural effusion which also resolved. Three patients were reported to have 
pulmonary nodules, but on follow-up two cases were found to be due to fibrotic 
changes or atelectasis and in the third case the lesion was benign rheumatoid in 
nature (Fig. 1).  This was confirmed on diagnostic MDCT (Fig. 2) along with a further 
lesion in the left upper lobe (Fig. 3) which was not within the area of the CTAC 
acquisition.  The lesions were surgically resected before a diagnosis of a benign 
condition was made.  There was also a para-spinal mass which was considered 
insignificant when followed up and an aortic aneurysm that did not warrant follow-up. 
 
Centre 2 used an Infinia Hawkeye 4-slice CT system. Out of 1011 patients they 
found 31 who were considered to have new significant incidental findings at the time 
of report.  However, only 2 had clinically significant pathology.  One patient was 
reported to have a pulmonary mass on the initial CTAC images (Fig.4).  This was 
confirmed with diagnostic MDCT (Fig.5) and MR, which demonstrated invasion of the 
right atrium with involvement of the atrial septum.  The mass was resected and 
confirmed as a 5-cm carcinoid lesion.  
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The second case at centre 2 with clinically significant pathology was confirmed as 
lung metastases from pancreatic cancer.  There was a further case of suspected 
pulmonary metastases which was later found to be Wegner’s granulomatosis. Three 
lung nodules at the time of report were considered to be insignificant at follow-up.  
As with centre 1, pulmonary effusions and consolidations considered to be significant 
at the time of the report had often resolved on follow-up imaging.  One case of lobar 
collapse was thought to be long-standing.  There were 8 cardiovascular cases which 
were considered significant in the CTAC report but this was not thought to be the 
case subsequently. 
 
Centre 3 used an Infinia Hawkeye 4-slice CT system. Out of 275 patients they found 
5 who had new significant incidental findings at the time of report, but none of these 
had clinically significant pathology. One patient was reported to have a pleural 
effusion but when followed up this was due to left ventricular failure.  Another patient 
was reported to have ground glass opacities but appearance 12 weeks later on the 
follow-up diagnostic MDCT thorax was normal.  A further patient was found to have 
atelectasis.  Two pulmonary nodules were identified; one was reclassified as 
emphysema with fissural thickening on follow-up imaging and the other (Fig. 6) was 
confirmed as a 6-mm pulmonary nodule by diagnostic MDCT (Fig. 7).  This was 
found to be stable over a 24-month follow-up period. 
 
Centre 4 used a Precedence 16-slice CT system. Out of 211 patients they found 3 
who had previously undiagnosed single pulmonary lung nodules (SPN) identified at 
the time of report.  All 3 SPNs were confirmed with follow-up CT.  One nodule 
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remained stable but the other two were confirmed carcinomas with staging of T3 
(two lesions within lobe) (Fig. 8) and the other T2a N0 M0 (Fig. 9). 
 
Implications of the findings 
 
The distinctive feature of this study is that it not only demonstrates the possibility of 
detecting incidental findings on CTAC, as already reported in current literature, but 
also goes on to evaluate the significance and value of those findings in relation to the 
quality of the images on which they have been detected.       
 
There is a common conception that detection of incidental findings will ultimately 
benefit the patient.12 Detection of pre-clinical disease on CTAC images could 
potentially lead to early and more effective treatment of the disease with a 
consequent improvement in patient outcome.  This would be consistent with the aim 
of a screening programme.  However, the overall detection rate (4 cancers detected 
out of 1819 patients) and the low PPV (8%) across all centres means that its value 
as an investigative procedure appears to be limited. 
 
Incidental findings that are considered to be significant or indeterminate at the time 
of reporting will warrant further diagnostic follow-up, which often carries with it a 
further risk to the patient.13   Diagnostic imaging usually has an associated radiation 
burden.  Similarly, intervention from biopsy or surgery will also involve associated 
risk to the patient.   
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Consideration of clinically relevant findings is important when patient outcome can 
be improved. 14 However, thought needs to be given to the proportion of false-
positives detected on the low-resolution CT images and over-diagnosis (where a 
cancer is detected that would not otherwise have become apparent in that patient’s 
lifetime).  These will undoubtedly result in patients having follow-up diagnostic tests 
which affect the balance of harms versus benefit to the patient. 12,15,16 Benefit 
exceeding harm is an important aspect of any diagnostic procedure. 12,15 
 
The case illustrated in Figs 1, 2 & 3 shows a good example of this.  Here, a 
pulmonary nodule was detected on CTAC and confirmed with diagnostic MDCT with 
identification of a further lesion.  Both lesions were surgically removed and 
subsequently found to be benign.  Ultimately, the resection of these asymptomatic 
lesions was found to be unnecessary, so there was no actual benefit to the patient. 
 
A large proportion of incidental findings are pulmonary in nature14 with pulmonary 
nodules being a frequent finding.13,17 There is considerable controversy surrounding 
whether CT screening for lung cancer is effective.13,18,19 A suitable screening test 
with a high enough sensitivity and specificity to reduce mortality from the detection of 
lung cancer has not yet been established and currently a lung cancer screening 
programme does not exist in the UK.13,14,18 Given that diagnostic quality images do 
not reduce mortality in this situation, it has to be questioned whether low-resolution 
CTAC images are likely to have any net patient benefit. 
 
As well as an increase in morbidity and mortality from follow-up and intervention, 
there is also the increase in healthcare costs to consider and an inevitable increase 
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in patient anxiety.13,17,20 There is an obvious psychological effect of diagnosing a 
healthy patient with disease, the effects of which can be long-term even after normal 
follow-up results. 21 Radiological imaging cannot always offer definitive reassurance. 
20,22 Patient tolerance of further imaging could be affected as a result, which could 
result in non-compliance with necessary imaging procedures. 14  
 
The CTAC images produced during SPECT-CT MPI are low-resolution and taken 
through a limited area of the thorax.  As such, not only will some cancers not be 
detected on the images but inevitably pathology outside the scan range will remain 
undetected.  Whilst pathology might be detected on the images, absence of 
pathology on the images does not mean that the patient is disease free. 
 
The varied CT performance among the centres in this study is an important 
consideration. Centre 4 (utilising the Philips Precedence 16-slice) performed 
considerably better than centres 2 and 3 (utilising the GE Infinia Hawkeye 4) and 
centre 1 (utilising GE Infinia Hawkeye 1).  This is consistent with the findings of the 
lesion detection phantom study performed by Thompson et al, 2014. 10 In our study 
the PPV at centre 4 was 67% compared with 6% for centre 2 and 0% from centres 1 
and 3.  The PPV for centre 4 was significantly better than for the other three centres 
combined (p=0.01 using Fisher’s exact test). In previous studies PPV for detection of 
pulmonary nodules with contrast enhanced diagnostic CT was found to be 80%. 23   
 
To give this some perspective, from 211 patients imaged with CTAC at centre 4, 3 
(1.4%) had significant new findings of which 2 (0.95%) lives were likely to be saved 
from lung cancer.  This is higher than the detection rate of the breast screening 
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programme (0.8%). Both patients were referred for surgical resection and have 
survived so far.  Of the 1011 patients imaged with CTAC at centre 2, 31 (3%) had 
new significant findings of which 1 (0.1%) had their life saved.  The 5 (1.8%) patients 
from centre 3 and 12 (3.7%) patients from centre 1 with new significant findings 
resulted in no improvement in patient outcome in relation to survival rate. 
 
With the equipment used at centre 4, image quality of the CTAC images would be 
expected to be closer to diagnostic quality than CTAC images acquired at the other 
three centres.  In particular, the short rotation time and overall scan time would 
greatly reduce the chance of motion artifact on the resultant images from patient 
respiration.  This would be inevitable on the images acquired with the much longer 
rotation times of the Infinia Hawkeye scanners, which are not designed for diagnostic 
quality imaging.  CTAC images from centre 4 had also been acquired with a smaller 
slice thickness and a low pitch factor leading to improved spatial resolution and 
reduced partial volume effect compared with CTAC images acquired at the other 
centres.   
 
It is likely that improved image quality will lead to improved confidence in reporting. 
For example, the radiologist from centre 1 who was used to viewing the CTAC 
images from the Infinia Hawkeye 1-slice system commented on the difficulty of 
expressing radiopacity in Hounsfield units because a larger slice thickness lead to  
greater partial volume averaging (Fig 10). 
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Conclusion 
The primary question addressed by this multi-centre study was to determine whether 
low-resolution CTAC images have diagnostic value and would warrant reporting. 
 
Poor quality CT images were produced by the centre which used the older GE 
Hawkeye 1 single slice system. This centre had a PPV of 0% and this study 
suggests these images do not warrant reporting. Good quality CT images were 
produced by the centre using the Philips Precedence system. This centre had a PPV 
of 67% and this study suggests that there is merit in reporting these images.  
 
The two centres using the GE Hawkeye 4 system produced medium quality CT 
images. These centres had PPVs of 0% and 6%, respectively. The PPVs are 
extremely low because most of the correctly identified new findings which were 
thought to be significant at the time of reporting turned out to be clinically 
insignificant after further investigation. Further research is clearly needed to establish 
the actual diagnostic value of CT used for attenuation correction in MPI, especially in 
the case of medium-resolution CT sub-systems in SPECT-CT scanners. 
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Tables 
Table 1 – Patient demographics 
Centre 1 2 3 4 All 
Male:Female 1:0.8 1:0.9 1:0.9 1:0.5 1:0.8 
Mean Age (years) 62.6 69.6 64.9 66.5 65.9 
Age Range (years) 36-85 40-91 25-89 42-83 25-91 
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Table 2 - Scan Parameters of the SPECT-CT Systems 
Centre 1 2 and 3 4 
Scanner 
GE Infinia 
Hawkeye 1 
1-slice 
GE Infinia 
Hawkeye 4 
4-slice 
Philips 
Precedence 
16-slice 
kV 120 120 120 
mA 2.5 1.5 ~33 
Rotation Time (s) 18 30 1.5 
Effective mAs 45 24 50 
Acquired slice thickness (mm) 10 5 1.5 
Reconstructed slice (mm) 10 6.1 5 
Pitch 1.0 1.9 0.98 
Contrast to noise ratio 2.4 2.2 0.74 
Low contrast resolution 3-mm 4-mm                4-mm 
High contrast resolution ≥ 4 lp/cm ≥ 3 lp/cm ≥ 24 lp/cm 
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Table 3 - Classification of Findings 
Classification Description 
Major (clinically significant) Requires further investigation in view of clinical 
information and history. This includes findings such as 
pleural effusions or lung nodules 
Minor Less significant than major findings; however they do 
have clinical significance. For example, cardiomegaly, 
liver lesions or hiatus hernia  
Minimal Less significant than minor findings, minimal or no clinical 
significance given patient history. These include 
degenerative changes. 
Equivocal Findings unclear. These include abnormalities in the liver 
that cannot be characterized. 
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Table 4 – Number of Incidental CTAC Findings 
 Centre 1 2 3 4 Total  
Total number of patients in study 322 1011 275 211 1819 
Number with positive finding 212 190 71 24 497 
Number with new positive findings 202 158 43 20 423 
 Clinically significant findings 12 31 5 3 51 
 Minor findings 62 66 31 2 161 
 Minimal findings 126 48 7 14 195 
 Equivocal findings 2 13 0 1 16 
Confirmed clinically significant 0 2 0 2 4 
Positive Predictive Value 0% 6% 0% 67% 8% 
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Table 5 - Characterisation of significant new CTAC findings. Numbers in 
parentheses represent the number of patients whose outcome was affected by the 
significant new finding. 
 Centre 
1 2 3 4 Total 
 
Pulmonary Nodules 3 3 2 3 (2) 11 
Mass 
 
3 (1) 
  
3 
Lung Metastases 
 
2 (1) 
  
2 
GGO 
  
1 
 
1 
Atelectasis 
  
1 
 
1 
Effusion 1 8 1 
 
10 
Consolidation 6 2 
  
8 
Ill-defined 
 
2 
  
2 
Pneumonia 
 
1 
  
1 
Lobar Collapse 
 
1 
  
1 
Total 10 (0) 22 (2) 5 (0) 3 (2) 40 (4) 
Cardiovascular Aortic Aneurysm 1 
   
1 
CAC 
 
8 
  
8 
Total 1 (0) 8 (0) 
  
9 (0) 
 25 
Para-spinal Mass 1 1 
  
2 
Total 1 (0) 1 (0) 
  
2 (0) 
 
GGO = Ground glass opacities 
CAC = Coronary artery calcification 
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Figure captions 
 
Fig. 1 Patient from centre 1. CTAC image acquired using GE Infinia Hawkeye 1-slice 
SPECT-CT system which reveals a single pulmonary nodule in the left lower lobe.  
This was confirmed by diagnostic CT (Fig 2) 
 
Fig. 2 Same patient as in Fig. 1 Diagnostic MDCT confirming diagnosis of pulmonary 
lesion detected on the CTAC acquisition 
 
Fig. 3 Same patient as in Figs. 1 and 2 Diagnostic MDCT demonstrating a further 
lesion in the left upper lobe 
 
Fig. 4 Patient from centre 2. CTAC image (lung windows) from cardiac SPECT-CT 
study using GE Infinia Hawkeye 4-slice demonstrating mass in right lower lobe 
abutting heart. 
 
Fig. 5 Same patient as in Fig. 4 Contrast enhanced diagnostic MDCT image 
demonstrating lung mass with serpiginous vessels 
 
Fig. 6 Patient from centre 3. CTAC images using GE Infinia Hawkeye 4-slice.  Red 
cross-hairs identifying an approximately 6 mm nodule. 
 
Fig. 7 Same patient as Fig 6. Diagnostic MDCT confirming presence of nodule (N3). 
This was considered stable on subsequent CT images over a period of 24 months. 
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Fig. 8 Patient from centre 4. CTAC image from Philips Precedence 16-slice MDCT 
demonstrating a right lower lobe nodule in a 77 year old male patient which was 
confirmed as T3 carcinoma at resection 
 
Fig. 9 Another patient from centre 4. CTAC image from Philips Precedence 16-slice 
MDCT demonstrating single pulmonary nodule in a 77 year old male patient which 
was confirmed as T2a N0 M0 
 
Fig. 10 illustrating a suspected pulmonary nodule on GE Infinia Hawkeye 1-slice 
CTAC image which was confirmed as pulmonary fibrosis on diagnostic MDCT. 
